Literature DB >> 15234336

Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders.

Antonella Peduto1, Matthias R Baumgartner, Nanda M Verhoeven, Daniel Rabier, Marco Spada, Marie-Cecile Nassogne, Bwee-Tien T Poll-The, Giovanni Bonetti, Cornelis Jakobs, Jean-Marie Saudubray.   

Abstract

Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these, pipecolic acid evaluation is considered as a supplementary test. We have established the diagnostic role of pipecolic acid in 30 patients affected by a peroxisomal defect (5 Zellweger syndromes, 10 Infantile Refsum diseases, 1 neonatal adrenoleukodystrophy, 6 patients affected by a peroxisomal biogenesis disorder with unclassified phenotype, 1 case of rhizomelic chondrodysplasia punctata (RCDP), 2 acyl-CoA oxidase deficiencies, 2 bifunctional enzyme deficiencies, 2 Refsum diseases, and 1 beta-oxidation deficiency). Pipecolic acid was increased in all generalized peroxisomal disorders, while normal pipecolic acid with abnormal very long chain fatty acid concentrations was strong evidence for a single peroxisomal enzyme deficiency. Unexpectedly, hyperpipecolic acidaemia was found also in a child affected by RCDP and in two patients with Refsum disease. In six patients the suggestion of a peroxisomal disorder was raised by the fortuitous finding of a pipecolic acid peak in amino acid chromatography, routinely performed as a general metabolic screening. For all patients, pipecolic acid proved to be a useful parameter in the biochemical classification of peroxisomal disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234336     DOI: 10.1016/j.ymgme.2004.04.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency.

Authors:  Philippa B Mills; Emma J Footitt; Serkan Ceyhan; Paula J Waters; Cornelis Jakobs; Peter T Clayton; Eduard A Struys
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

Review 2.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

3.  Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.

Authors:  Andrew D Patterson; Jessica A Bonzo; Fei Li; Kristopher W Krausz; Gabriel S Eichler; Sadaf Aslam; Xenia Tigno; John N Weinstein; Barbara C Hansen; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

4.  Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.

Authors:  Thushanthi Perera; Matthew R Young; Zhiying Zhang; Gwen Murphy; Nancy H Colburn; Elaine Lanza; Terryl J Hartman; Amanda J Cross; Gerd Bobe
Journal:  Mol Nutr Food Res       Date:  2015-02-23       Impact factor: 5.914

5.  Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).

Authors:  Philippa B Mills; Emma J Footitt; Kevin A Mills; Karin Tuschl; Sarah Aylett; Sophia Varadkar; Cheryl Hemingway; Neil Marlow; Janet Rennie; Peter Baxter; Olivier Dulac; Rima Nabbout; William J Craigen; Bernhard Schmitt; François Feillet; Ernst Christensen; Pascale De Lonlay; Mike G Pike; M Imelda Hughes; Eduard A Struys; Cornelis Jakobs; Sameer M Zuberi; Peter T Clayton
Journal:  Brain       Date:  2010-06-16       Impact factor: 13.501

6.  A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.

Authors:  S J Steinberg; A Snowden; N E Braverman; L Chen; P A Watkins; P T Clayton; K D R Setchell; J E Heubi; G V Raymond; A B Moser; H W Moser
Journal:  J Inherit Metab Dis       Date:  2008-12-25       Impact factor: 4.982

7.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

8.  The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literature.

Authors:  Malena Daich Varela; Priyam Jani; Wadih M Zein; Precilla D'Souza; Lynne Wolfe; Jennifer Chisholm; Christopher Zalewski; David Adams; Blake M Warner; Laryssa A Huryn; Robert B Hufnagel
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-31       Impact factor: 3.359

Review 9.  The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders.

Authors:  Sacha Ferdinandusse; Merel S Ebberink; Frédéric M Vaz; Hans R Waterham; Ronald J A Wanders
Journal:  J Inherit Metab Dis       Date:  2016-03-04       Impact factor: 4.982

10.  Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy.

Authors:  Jiao Xue; Junjuan Wang; Pan Gong; Minhang Wu; Wenshuang Yang; Shiju Jiang; Ye Wu; Yuwu Jiang; Yuehua Zhang; Tatiana Yuzyuk; Hong Li; Zhixian Yang
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.